The nonsteroidal anti-inflammatory drug sulindac reverses obesity-driven immunosuppression and triple-negative breast cancer progression
非甾体抗炎药舒林酸可逆转肥胖引起的免疫抑制和三阴性乳腺癌的进展。
期刊:Breast Cancer Research
影响因子:5.6
doi:10.1186/s13058-025-02134-2
Coleman, Michael F; McDonell, Shannon B; Eisenbeis, Lydia K; Devericks, Emily N; Chandi, Jobin; Dave, Om; Pearce, Jane B; Wang, Sylvia; Cody, Morgan; Bustamante-Marin, Ximena M; Glenny, Elaine M; Rezeli, Erika T; Cozzo, Alyssa J; O'Flanagan, Ciara H; Bathon, Brooke E; Shaikh, Saame Raza; Milne, Ginger L; Wendt, Michael K; Lanman, Nadia A; Teegarden, Dorothy; Hursting, Stephen D
